Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Penalized longitudinal mixed models with latent group structure, with an application in neurodegenerative diseases

Farhad Hatami, Konstantinos Perrakis, Johnathan Cooper-Knock, Sach Mukherjee, Frank Dondelinger
doi: https://doi.org/10.1101/2020.11.10.20229302
Farhad Hatami
1Centre for Health Informatics, Computation and Statistics, Lancaster Medical School, Lancaster University, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: f.hatami@lancaster.ac.uk
Konstantinos Perrakis
2Department of Mathematical Sciences, Durham University, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johnathan Cooper-Knock
3Department of Neuroscience, The University of Sheffield
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sach Mukherjee
4German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Dondelinger
1Centre for Health Informatics, Computation and Statistics, Lancaster Medical School, Lancaster University, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Summary

Large-scale longitudinal data are often heterogeneous, spanning latent subgroups such as disease subtypes. In this paper, we present an approach called longitudinal joint cluster regression (LJCR) for penalized mixed modelling in the latent group setting. LJCR captures latent group structure via a mixture model that includes both the multivariate distribution of the covariates and a regression model for the response. The longitudinal dynamics of each individual are modeled using a random effect intercept and slope model. Inference is done via a profile likelihood approach that can handle high-dimensional covariates via ridge penalization. LJCR is motivated by questions in neurodegenerative disease research, where latent subgroups may reflect heterogeneity with respect to disease presentation, progression and diverse subject-specific factors. We study the performance of LJCR in the context of two longitudinal datasets: a simulation study and a study of amyotrophic lateral sclerosis (ALS). LJCR allows prediction of progression as well as identification of subgroups and subgroup-specific model parameters.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT01141023, PMC4239834

Funding Statement

This work has been supported by the Academy of Medical Sciences.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All the modeling part and results have been scrutinized by experts in the field of Biostatistics

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The ALS PRO-ACT data is publicly available. Parkinson's disease data (PPMI) can be found at the following link

https://nctu.partners.org/ProACT/

http://www.ppmi-info.org/access-data-specimens/download-data/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted November 13, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Penalized longitudinal mixed models with latent group structure, with an application in neurodegenerative diseases
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Penalized longitudinal mixed models with latent group structure, with an application in neurodegenerative diseases
Farhad Hatami, Konstantinos Perrakis, Johnathan Cooper-Knock, Sach Mukherjee, Frank Dondelinger
medRxiv 2020.11.10.20229302; doi: https://doi.org/10.1101/2020.11.10.20229302
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Penalized longitudinal mixed models with latent group structure, with an application in neurodegenerative diseases
Farhad Hatami, Konstantinos Perrakis, Johnathan Cooper-Knock, Sach Mukherjee, Frank Dondelinger
medRxiv 2020.11.10.20229302; doi: https://doi.org/10.1101/2020.11.10.20229302

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Informatics
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (557)
  • Anesthesia (135)
  • Cardiovascular Medicine (1769)
  • Dentistry and Oral Medicine (239)
  • Dermatology (173)
  • Emergency Medicine (316)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10812)
  • Forensic Medicine (8)
  • Gastroenterology (594)
  • Genetic and Genomic Medicine (2960)
  • Geriatric Medicine (288)
  • Health Economics (534)
  • Health Informatics (1933)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (293)
  • HIV/AIDS (633)
  • Infectious Diseases (except HIV/AIDS) (12525)
  • Intensive Care and Critical Care Medicine (696)
  • Medical Education (300)
  • Medical Ethics (87)
  • Nephrology (324)
  • Neurology (2809)
  • Nursing (152)
  • Nutrition (433)
  • Obstetrics and Gynecology (560)
  • Occupational and Environmental Health (597)
  • Oncology (1473)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (257)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (381)
  • Pediatrics (868)
  • Pharmacology and Therapeutics (367)
  • Primary Care Research (338)
  • Psychiatry and Clinical Psychology (2647)
  • Public and Global Health (5383)
  • Radiology and Imaging (1016)
  • Rehabilitation Medicine and Physical Therapy (597)
  • Respiratory Medicine (727)
  • Rheumatology (330)
  • Sexual and Reproductive Health (290)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (48)
  • Transplantation (150)
  • Urology (126)